• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Inc ALNY 2 Star

Last Price$87.99Day Change (%)2.10%
Open Price$87.96Day Change ($)1.81
Day Range86.19–88.3952-Week Range47.03–112.57

As of Mon 10/20/2014 03:51 PM EST | USD

  1. All
  2. 3rd Party
  1. Alnylam Reports Six-Month Clinical Data from Patisiran Phase 2 Open-Label Extension (OLE) Study in Patients with Familial Amyloidotic Polyneuropathy (FAP)

    Alnylam Reports Six-Month Clinical Data from Patisiran Phase 2 Open-Label Extension (OLE) Study in Patients with Familial Amyloidotic Polyneuropathy (FAP)

  2. Research and Markets: Global Paroxysmal Nocturnal Hemoglobinuria Therapeutics Pipeline 2014 - 5 Companies & 9 Drug Profiles

    Research and Markets: Global Paroxysmal Nocturnal Hemoglobinuria Therapeutics Pipeline 2014 - 5 Companies & 9 Drug Profiles

  3. Investing in Hidden Assets

    Use this screen to find high-growth businesses that have big ideas to keep competitors at bay.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.